Home › Endometrial Cancer › Connecticut › Hartford
Endometrial Cancer clinical trials in Hartford, CT
5 studies for Endometrial Cancer are looking for participants at sites in and around Hartford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Hartford Hospital, Hartford
- Hartford HealthCare - Manchester, Manchester · 8 mi away
- The Hospital of Central Connecticut, New Britain · 9 mi away
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RecruitingPhase 3
- Hartford Hospital, Hartford
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
RecruitingObservational study
- Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 8 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Hartford
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Chicago, IL25 studies
- Columbus, OH25 studies
- Queens, NY25 studies
Other studies in Hartford
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer11 studies
- Major Depressive Disorder9 studies
- Cancer (all types)9 studies
- Breast Cancer9 studies
- Neuroblastoma8 studies
- Multiple Myeloma7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer7 studies
- Ovarian Cancer7 studies
- Cardiovascular Disease7 studies
- Heart Failure7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.